Staff Publications: October 2017

  1. Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of RAC1-Driven Malignant Melanoma by Group a PAK Inhibitors. Oncogene. 2018;37(7):944-952. PMID: 29059171. PMC5814328.
  2. Aras S, Zaidi MR. Tameless Traitors: Macrophages in Cancer Progression and Metastasis. Br J Cancer. 2017;117(11):1583-1591. PMID: 29065107. PMC5729447.
  3. Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin Regulates Head and Neck Squamous Cell Carcinoma Invasion by Modulating Matrix Metalloproteases. J Cell Physiol. 2018;233(1):409-421. PMID: 28295306. PMC5592128. NIHMS860681.
  4. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol 2018;73:262-70. Eur Urol. 2018;73(4):e98-e99. PMID: 29032846.
  5. Balar AV, Castellano D, O’Donnell PH, et al. First-Line Pembrolizumab in Cisplatin-Ineligible Patients with Locally Advanced and Unresectable or Metastatic Urothelial Cancer (Keynote-052): A Multicentre, Single-Arm, Phase 2 Study. Lancet Oncol. 2017;18(11):1483-1492. PMID: 28967485.
  6. Bamias A, Tzannis K, Harshman LC, et al. Impact of Contemporary Patterns of Chemotherapy Utilization on Survival in Patients with Advanced Cancer of the Urinary Tract: A Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). Ann Oncol. 2018;29(2):361-369. PMID: 29077785.
  7. Beatty A, Fink LS, Singh T, et al. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer. Mol Cancer Ther. 2018;17(1):264-275. PMID: 29021292. PMC5892195.
  8. Chen M, Ko HY, Remsing RC, et al. Ab Initio Theory and Modeling of Water. Proc Natl Acad Sci USA. 2017;114(41):10846-10851. PMID: 28973868. PMC5642722.
  9. Dmitrieva O, Grivennikov SI. Microbiota and Cancer: A Complex Equation with a Lot of Exciting Unknowns. Semin Immunol. 2017;32:1-2. PMID: 29078919. Editorial.
  10. Dong Y, Zaorsky NG, Li T, et al. Effects of Interruptions of External Beam Radiation Therapy on Outcomes in Patients with Prostate Cancer. J Med Imaging Radiat Oncol. 2018;62(1):116-121. PMID: 29030906. PMC5800942.
  11. Dotan E. Adjusting Our Current Practice to Better Care for the Older Patient with Cancer. J Oncol Pract. 2017;13(2):103-104. PMID: 28972828.
  12. Esposito AC, Crawford J, Sigurdson ER, et al. Omission of Radiotherapy after Breast Conservation Surgery in the Postneoadjuvant Setting. J Surg Res. 2018;221:49-57. PMID: 29229152. PMC5729922.
  13. Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL. Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report. Pancreas. 2017;46(10):1381-1385. PMID: 29040196.
  14. Gregory K, Schiech L. Helping Patients Cope with Secondary Lymphedema. Nursing. 2017.
  15. Gregory K, Schiech L. Looking into Secondary Lymphedema. Nursing. 2017;47(11):34-42. PMID: 28991070.
  16. Horn L, Spigel DR, Vokes EE, et al. Nivolumab Versus Docetaxel in Previously Treated Patients with Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes from Two Randomized, Open-Label, Phase III Trials (Checkmate 017 and Checkmate 057). J Clin Oncol. 2017;35(35):3924-3933. PMID: 29023213. PMC6075826.
  17. Ingram JP, Brodsky IE, Balachandran S. Interferon-γ in Salmonella Pathogenesis: New Tricks for an Old Dog. Cytokine. 2017;98:27-32. PMID: 27773552. PMC5398957.
  18. Jain R, Denlinger CS. Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions. Obesity (Silver Spring). 2017;25 Suppl 2:S27-S29. PMID: 29086512. PMC5744874.
  19. Johnson N, Liao JB. Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium. Int J Gynecol Cancer. 2017;27(9S Suppl 5):S14-S19. PMID: 29040190.
  20. Kischkel S, Bergt S, Brock B, et al. In Vivo Testing of Extracorporeal Membrane Ventilators: iLA-Activve versus Prototype I-Lung. ASAIO J. 2017;63(2):185-192. PMID: 28092273.
  21. Lee HO, Uzzo RG, Kister D, Kruger WD. Combination of Serum Histidine and Plasma Tryptophan as a Potential Biomarker to Detect Clear Cell Renal Cell Carcinoma. J Transl Med. 2017;15(1):72. PMID: 28385150. PMC5383954.
  22. Lev A, Deihimi S, Shagisultanova E, et al. Preclinical Rationale for Combination of Crizotinib with Mitomycin C for the Treatment of Advanced Colorectal Cancer. Cancer Biol Ther. 2017;18(9):694-704. PMID: 28886275. PMC5663405.
  23. Lev A, Lulla AR, Wagner J, et al. Anti-Pancreatic Cancer Activity of ONC212 Involves the Unfolded Protein Response (UPR) and Is Reduced by IGF1-R and GRP78/BIP. Oncotarget. 2017;8(47):81776-81793. PMID: 29137221. PMC5669847.
  24. Li JG, Barrero C, Merali S, Pratico D. Genetic Absence of ALOX5 Protects from Homocysteine-Induced Memory Impairment, Tau Phosphorylation and Synaptic Pathology. Hum Mol Genet. 2017;26(10):1855-1862. PMID: 28334897. PMC6075360.
  25. Li M, Sohn JA, Seeger C. Distribution of Hepatitis B Virus Nuclear DNA. J Virol. 2018;92(1). PMID: 29046450. PMC5730781.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of cGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800.
  27. Liu Y, Yuelling LW, Wang Y, et al. Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion. Cancer Res. 2017;77(23):6692-6703. PMID: 28986380. PMC5759326.
  28. Lulla AR, Slifker MJ, Zhou Y, et al. miR-6883 Family MiRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells. Cancer Res. 2017;77(24):6902-6913. PMID: 29061672.
  29. Lyubitelev AV, Studitsky VM, Feofanov AV, Kirpichnikov MP. Effect of Sodium and Potassium Ions on Conformation of Linker Parts of Nucleosomes. Moscow University Biological Sciences Bulletin. 2017;72(3):146-150.
  30. Maifrede S, Magimaidas A, Sha X, Mukherjee K, Liebermann DA, Hoffman B. Loss of Egr1, a Human del5q Gene, Accelerates BCR-ABL Driven Chronic Myelogenous Leukemia. Oncotarget. 2017;8(41):69281-69294. PMID: 29050203. PMC5642478.
  31. Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case Series of Multiple Primary Cancers in Single Individuals: Diagnostic and Therapeutic Dilemmas. J Community Hosp Intern Med Perspect. 2017;7(4):238-240. PMID: 29046751. PMC5637644.
  32. Mateos-Gomez PA, Kent T, Deng SK, et al. The Helicase Domain of Polθ Counteracts RPA to Promote alt-NHEJ. Nat Struct Mol Biol. 2017;24(12):1116-1123. PMID: 29058711. PMC6047744.
  33. Mesa RA, Jamieson C, Bhatia R, et al. NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. J Natl Compr Canc Netw. 2017;15(10):1193-1207. PMID: 28982745.
  34. Michailidou K, Lindstrom S, Dennis J, et al. Association Analysis Identifies 65 New Breast Cancer Risk Loci. Nature. 2017;551(7678):92-94. PMID: 29059683. PMC5798588.
  35. Milne RL, Kuchenbaecker KB, Michailidou K, et al. Identification of Ten Variants Associated with Risk of Estrogen-Receptor-Negative Breast Cancer. Nat Genet. 2017;49(12):1767-1778. PMID: 29058716. PMC5808456.
  36. Mortazavi G, Mortazavi SAR, Mortazavi SMJ. Comments on “Association of Excessive Mobile Phone Use During Pregnancy with Birth Weight: An Adjunct Study in Kumamoto of Japan Environment and Children’s Study”. Environmental Health and Preventive Medicine. 2017;22(1).
  37. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Phys Med. 2018;47:144. PMID: 29032028.
  38. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body Gamma-Irradiated Mice”. Environ Mol Mutagen. 2018;59(2):170-171. PMID: 29067715.
  39. Mortazavi SMJ. Comments on “Study of Bacterial Contamination of Mobile Phones and Stethoscopes in Neonatal Intensive Care Unit”. International Journal of Pediatrics-Mashhad. 2017;5(11):6143-6144.
  40. Mortazavi SMJ. Comments on Analysis of Mobile Phone Use among Young Patients with Brain Tumors in Japan. Bioelectromagnetics. 2017;38(8):653-654. PMID: 28980326.
  41. Mortazavi SMJ. Re: “Modeled and Perceived Exposure to Radiofrequency Electromagnetic Fields from Mobile-Phone Base Stations and the Development of Symptoms over Time in a General Population Cohort”. Am J Epidemiol. 2017;186(10):1217. PMID: 29036398.
  42. Mortazavi SMJ. Re: Are Electromagnetic Fields in Incubators a Risk Factor for Autism? Acta Paediatr. 2017;106(12):2063. PMID: 28862780.
  43. Mortazavi SMJ, Mortazavi G, Paknahad M. Comment on Sundseth et. al. Global Sources and Pathways of Mercury in the Context of Human Health. Int. J. Environ. Res. Public Health 2017, 14, 105. Int J Environ Res Public Health. 2017;14(5). PMID: 28475133. PMC5451932.
  44. Mustian KM, Peppone LJ, Miller SM. Difficulties in Defining and Measuring Cancer-Related Fatigue-Reply. JAMA Oncol. 2018;4(3):419-420. PMID: 28983561.
  45. Naaman H, Rall G, Matullo C, Veksler-Lublinsky I, Shemer-Avni Y, Gopas J. MiRNA-124 is a Link between Measles Virus Persistent Infection and Cell Division of Human Neuroblastoma Cells. PLoS One. 2017;12(10):e0187077. PMID: 29073265. PMC5658143.
  46. Nieborowska-Skorska M, Maifrede S, Dasgupta Y, et al. Ruxolitinib-Induced Defects in DNA Repair Cause Sensitivity to PARP Inhibitors in Myeloproliferative Neoplasms. Blood. 2017;130(26):2848-2859. PMID: 29042365. PMC5746670.
  47. Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program from Theory through Implementation and Assessment. Rehabilitation Oncology. 2017;35(4):172-180.
  48. Paudyal SC, Li S, Yan H, Hunter T, You Z. DNA2 Initiates Resection at Clean DNA Double-Strand Breaks. Nucleic Acids Res. 2017;45(20):11766-11781. PMID: 28981724. PMC5714177.
  49. Pelosi G, Sonzogni A, Harari S, et al. Classification of Pulmonary Neuroendocrine Tumors: New Insights. Transl Lung Cancer Res. 2017;6(5):513-529. PMID: 29114468. PMC5653522.
  50. Pickhardt PJ, Edwards K, Bruining DH, et al. Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Dis Colon Rectum. 2017;60(11):1162-1167. PMID: 28991080. PMC5635837. NIHMS860683.
  51. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937.
  52. Ragin C, Blackman E, Roberts R, et al. Cancer in Populations of African Ancestry: Studies of the African Caribbean Cancer Consortium. Cancer Causes Control. 2017;28(11):1173-1176. PMID: 29086217. PMC5682212.
  53. Ralff MD, Lulla AR, Wagner J, El-Deiry WS. ONC201: A New Treatment Option Being Tested Clinically for Recurrent Glioblastoma. Translational Cancer Research. 2017;6:S239-S243.
  54. Ristau BT, Chen DYT, Ellis J, et al. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. J Urol. 2018;199(4):969-975. PMID: 28988963.
  55. Salem ME, Weinberg BA, Xiu J, et al. Comparative Molecular Analyses of Left-Sided Colon, Right-Sided Colon, and Rectal Cancers. Oncotarget. 2017;8(49):86356-86368. PMID: 29156800. PMC5689690.
  56. Seo HS, Habas R, Chang C, Wang J. Bimodal Regulation of Dishevelled Function by Vangl2 During Morphogenesis. Hum Mol Genet. 2017;26(11):2053-2061. PMID: 28334810. PMC6075608.
  57. 57. Shastri A, Janakiram M, Mantzaris I, et al. Sites of Extranodal Involvement Are Prognostic in Patients with Stage 1 Follicular Lymphoma. Oncotarget. 2017;8(45):78410-78418. PMID: 29108238. PMC5667971.
  58. Shi X, Ba R, You H, et al. A Rare Case of B-Lymphoproliferative Disorder with Villous Lymphocytes Harboring t(8;14)(q24;q32) Translocation. Front Med. 2018;12(3):324-329. PMID: 29075958.
  59. Spiess PE, Agarwal N, Bangs R, et al. Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(10):1240-1267. PMID: 28982750.
  60. Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. AHNS Series: Do You Know Your Guidelines? Review of Current Knowledge on Laryngeal Cancer. Head Neck. 2018;40(1):170-181. PMID: 29076227.
  61. Tawbi HA, Burgess M, Bolejack V, et al. Pembrolizumab in Advanced Soft-Tissue Sarcoma and Bone Sarcoma (SARC028): A Multicentre, Two-Cohort, Single-Arm, Open-Label, Phase 2 Trial. Lancet Oncol. 2017;18(11):1493-1501. PMID: 28988646.
  62. Ursu O, Gosline SJC, Beeharry N, et al. Network Modeling of Kinase Inhibitor Polypharmacology Reveals Pathways Targeted in Chemical Screens. PLoS One. 2017;12(10):e0185650. PMID: 29023490. PMC5638242.
  63. Xu Q, Fan J, Grimm J, et al. The Dosimetric Impact of the Prescription Isodose Line (Idl) on the Quality of Robotic Stereotactic Radiosurgery (SRS) Plans. Med Phys. 2017;44(12):6159-6165. PMID: 29064585.
  64. Zeng K, Tian L, Sirek A, et al. PAK1 Mediates the Stimulatory Effect of Insulin and Curcumin on Hepatic Chrebp Expression. J Mol Cell Biol. 2017;9(5):384-394. PMID: 28992163. PMC5907843.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s